½ÃÀ庸°í¼­
»óǰÄÚµå
1529974

ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç°º°, ´Ü°èº°, ¼­ºñ½ºº°, Áö¿ªº° ½ÃÀå ÇöȲ

Clinical Trial Biorepository and Archiving Solutions Market, By Product, By Phase, By Services, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀº 2024³â 45¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. 2031³â¿¡´Â 88¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2031³â°£ ¿¬Æò±Õ 10.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼³»¿ë
±âÁس⵵ 2023³â 2024³â ½ÃÀå ±Ô¸ð 45¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£(2024-2031³â) CAGR 10.20% 2031³â ±Ý¾× Àü¸Á 88¾ï 8,000¸¸ ´Þ·¯
±×¸². ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«À̺ù ¼Ö·ç¼Ç ½ÃÀå Á¡À¯À²(%), 2024³â, Áö¿ªº°
Clinical Trial Biorepository and Archiving Solutions Market-IMG1

ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ¼¼°è ½ÃÀå ¼ºÀåÀº Àü ¼¼°èÀûÀ¸·Î ÁøÇàµÇ´Â ´Ù¾çÇÑ ÀÓ»ó½ÃÇè°ú °ü·ÃµÈ Áß¿äÇÑ µ¥ÀÌÅ͸¦ È¿À²ÀûÀ¸·Î º¸°üÇÏ´Â ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮´Â ÀÓ»ó½ÃÇè ¹× ¿¬±¸ Ȱµ¿ Áß¿¡ äÃëÇÑ Ç÷¾×, Á¶Á÷, ¼Òº¯, ±âŸ ü¾×°ú °°Àº »ý¹°ÇÐÀû »ùÇÃÀ» ¾ÈÀüÇÏ°Ô º¸°üÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» ¸»ÇÕ´Ï´Ù. À̸¦ ÅëÇØ ¾ö°ÝÇÑ ±ÔÁ¤À» ÁؼöÇϸ鼭 Àå±â°£¿¡ °ÉÃÄ »ùÇÃÀÇ ¹«°á¼ºÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ¾ÆÄ«ÀÌºê ¼Ö·ç¼ÇÀº µ¥ÀÌÅÍ À¯Ãâ ¹× ¼Õ»ó À§ÇèÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¹æ´ëÇÑ ¾çÀÇ ÀÓ»ó½ÃÇè ¹®¼­¿Í µ¥ÀÌÅ͸¦ ¾ÈÀüÇÏ°Ô º¸°üÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ¾à¸®ÇÐ ºÐ¾ßÀÇ R&D ÅõÀÚ Áõ°¡¿Í ÀÓ»ó½ÃÇèÀÇ º¹À⼺À¸·Î ÀÎÇØ °íǰÁú ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«À̺ê ÀÎÇÁ¶ó¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°è ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀº ÁÖ·Î Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ Ã¤Åà Áõ°¡¿Í Á¦¾àȸ»çÀÇ ¿¬±¸ºñ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÓ»ó½ÃÇèÀÌ º¹ÀâÇØÁü¿¡ µû¶ó ÀÓ»ó½ÃÇè¿¡¼­ »ý¼ºµÈ »ùÇðú µ¥ÀÌÅ͸¦ ¾ÈÁ¤ÀûÀ¸·Î ÀúÀå, ÃßÀû, º¸°üÇØ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× ½Ã·á º¸°ü¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÁöħÀ¸·Î ÀÎÇØ ±â¾÷µéÀº ÷´Ü ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 °ü¸® ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÒ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. ±×·¯³ª ´ë±Ô¸ð ½Ã·á º¸°ü ½Ã¼³ÀÇ ³ôÀº ¼³Ä¡ ¹× À¯Áöº¸¼ö ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¼­ºñ½º ¾Æ¿ô¼Ò½Ì Áõ°¡¿Í ¿Âµµ Á¦¾î GPS ÀÚ»ê ÃßÀû ±â¼úÀÇ ÃâÇöÀº ½ÃÀå ¼ºÀåÀÇ ±âȸ·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â ¼¼°è ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È ½ÃÀå ±Ô¸ð(¹ÌÈ­ 10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ¿¹ÃøÇÑ º¸°í¼­ÀÔ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë ¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map (COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå, Á¦Ç°º°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ÀüÀÓ»ó Á¦Ç°
  • ÀÓ»ó Á¦Ç°

Á¦6Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå, »óº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ´Ü°è I
  • ´Ü°è II
  • ´Ü°è III
  • ´Ü°è IV

Á¦7Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå, ¼­ºñ½ºº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¼­ºñ½º
  • â°í º¸°ü
  • ¿î¼Û
  • »ùÇà ó¸®
  • ±âŸ
  • ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ¼­ºñ½º
  • µ¥ÀÌÅͺ£À̽º À妽º ÀÛ¼º ¹× °ü¸®
  • Scanning & Destruction

Á¦8Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå, Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Azenta US, Inc.
    • Thermo Fisher Scientific Inc.
    • Precision for Medicine, Inc.
    • Medpace
    • LabCorp Drug Development
    • ATCC
    • Q2 Solutions
    • Labconnect
    • Charles River Laboratories
    • Cell&Co
    • Trelleborg Sealing Solutions
    • Freudenberg Group
    • Saint-Gobain
    • Bal Seal Engineering, Inc.
    • Sterne SAS
    • ResMed

Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • À¶¼º°ú ¼èÅð
  • COM(Coherent Opportunity Map)

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
LSH 24.08.26

Global clinical trial biorepository and archiving solutions market is estimated to be valued at USD 4.51 Bn in 2024 and is expected to reach USD 8.88 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 4.51 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 10.20% 2031 Value Projection: US$ 8.88 Bn
Figure. Clinical Trial Biorepository and Archiving Solutions Market Share (%), By Region 2024
Clinical Trial Biorepository and Archiving Solutions Market - IMG1

Global clinical trial biorepository and archiving solutions market growth is driven by rising demand for efficient ways to store critical data associated with various clinical trials conducted worldwide. Biorepositories provide effective solutions for safely storing biological samples such as blood, tissues, urine, and other bodily fluids collected during clinical trials and research activities. These help in maintaining sample integrity for extended periods while ensuring compliance with stringent regulations. Moreover, archiving solutions enable organizations to securely archive vast amounts of clinical trial documents and data with minimal risk of data loss or corruption. Rising R&D investments in pharmacology and increasing complexity of clinical trials boosts the need for high-quality biorepository and archiving infrastructure.

Market Dynamics:

Global clinical trial biorepository and archiving solutions market growth is primarily driven by rising adoption of innovative therapies and growing research expenditures of pharmaceutical companies. As clinical trials become more complex, there is an increasing need for reliable storage, tracking, and archiving of samples and data generated during these studies. Stringent regulatory guidelines regarding data privacy and sample preservation compel organizations to invest in advanced biorepository management solutions. However, high installation and maintenance costs of large sample storage facilities can hamper the market growth. Increasing outsourcing of biorepository services and emergence of temperature-controlled GPS asset tracking technologies offer opportunities for the market growth.

Key Features of the Study:

  • This report provides in-depth analysis of the global clinical trial biorepository and archiving solutions market and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global clinical trial biorepository and archiving solutions market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Brookhaven Biolabs, Fisher Clinical Services, Hamilton Company, VWR International LLC, and PPD
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global clinical trial biorepository and archiving solutions market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical trial biorepository and archiving solutions market

Detailed Segmentation-

  • By Product
    • Preclinical Products
    • Clinical Products
  • By Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • By Services
    • Biorepository Services
    • Warehousing & Storage
    • Transportation
    • Sample Processing
    • Others
    • Archiving Solution Services
    • Database Indexing and Management
    • Scanning & Destruction
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Azenta U.S., Inc.
    • Thermo Fisher Scientific Inc.
    • Precision for Medicine, Inc.
    • Medpace
    • LabCorp Drug Development
    • ATCC
    • Q2 Solutions
    • Labconnect
    • Charles River Laboratories
    • Cell&Co
    • Trelleborg Sealing Solutions
    • Freudenberg Group
    • Saint-Gobain
    • Bal Seal Engineering, Inc.
    • Sterne S.A.S.
    • ResMed

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Phase
    • Market Snapshot, By Services
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Clinical Trial Biorepository and Archiving Solutions Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Clinical Trial Biorepository and Archiving Solutions Market, By Product, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Preclinical Products
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Clinical Products
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Clinical Trial Biorepository and Archiving Solutions Market, By Phase, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Phase I
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Phase II
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Phase III
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Phase IV
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Clinical Trial Biorepository and Archiving Solutions Market, By Services, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Biorepository Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Warehousing & Storage
  • Transportation
  • Sample Processing
  • Others
  • Archiving Solution Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Database Indexing and Management
  • Scanning & Destruction

8. Global Clinical Trial Biorepository and Archiving Solutions Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Azenta U.S., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Precision for Medicine, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medpace
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LabCorp Drug Development
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ATCC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Q2 Solutions
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Labconnect
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Charles River Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cell&Co
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Trelleborg Sealing Solutions
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Freudenberg Group
    • Saint-Gobain
    • Bal Seal Engineering, Inc.
    • Sterne S.A.S.
    • ResMed

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦